Hybribio products

The Stool DNA Methylation Real-time PCR Kit serves as a diagnostic tool for individuals at high risk of colorectal cancer, facilitating in vitro qualitative detection of methylated SDC2 and TFPI2 genes within intestinal exfoliated cells. Designed for efficacy and user-friendliness, this kit enables easy operation while maintaining a short processing time without the unpleasant odor associated with stool samples. It boasts a sensitivity of 95.3% and specificity of 90.3%, making it a reliable choice for accurate results. Additionally, the kit is available in configurations of 48 or 96 tests per kit, catering to varying volume needs in laboratories. This product supports research and clinical diagnostics, enabling the identification of potential cancer development markers, thus providing vital insights for early intervention and treatment planning.

The High-risk HPV GenoArray Diagnostic Kit is crafted specifically for the qualitative detection of 14 prominent high-risk human papillomavirus (HPV) genotypes, including types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68. This kit utilizes a universal probe capable of indicating other HPV infections, making it a versatile tool for comprehensive HPV screening. It features an internal quality control system with amplification control and hybridization control (Biotin) to ensure accurate and reliable detection through every phase of the analysis. The kit is compatible with several PCR instruments like the ABI 2720 and the Eppendorf PCR (Matercycler nexus), and it supports hybridization with devices such as HHM-3 and HBHM-9000A. Packaged with components sufficient for 30 tests, the kit retains its validity for 12 months. This product is intended for technical professionals engaged in HPV research or clinical HPV diagnostics.

Hybribio offers advanced Real-time PCR Kits designed for the qualitative detection of gene polymorphisms in human whole blood. These kits are optimized for in vitro applications, particularly targeting polymorphisms at the CYP2C19 gene locus including CYP2C19*2(G>A), CYP2C19*3(G>A), and CYP2C19*17(C>T). The product is instrumental for clinicians as it aids in making informed decisions regarding the administration of clopidogrel, although it is not to be used as the sole basis for clinical diagnosis. The kits are compatible with real-time fluorescence quantitative PCR instruments such as HongshiSLAN-96S and Roche Light Cycler 480 Ⅱ, and come with a specification of 48 tests per kit. Clinicians are encouraged to incorporate test results with patient symptoms, medical history, and other tests to optimize clinical management. The product focuses on enhancing human life through detailed genetic analysis.